189 petitions

Update posted 17 hours ago

Petition to Teva Pharmaceutical USA

Generics are still out of reach: Tell Teva to lower the price of lifesaving EpiPens

Over the last eleven years, EpiPens have gotten more expensive and more scarce. Since Mylan bought EpiPen in 2007, they’ve increased the price from $100 to over $600 for a two-pack. But Myan has also had issues keeping up with demand, with supplies running out regularly. Kids and adults with severe peanut, bee, and other allergies could go into anaphylactic shock and die without this life saving drug. That’s why the Food and Drug Administration (FDA) pushed for Teva Pharmaceutical USA to sell a cheaper generic version of the EpiPen in August 2018. But Teva’s generic EpiPen is still out of reach for many, with a price tag of $300 for a two pack! That’s the same as Myan’s generic version. This isn’t what the FDA had in mind. Generics should be more affordable. Demand Teva lower the price of their EpiPens! While Teva’s generic EpiPen is less than the name brand’s sticker price, it is still three times the cost of the original EpiPen. It’s an anaphylaxis-reversing injector, essentially EpiPens allow people to save themselves if they come into contact with things they are allergic to. Fifteen million Americans have food allergies, and that includes six million kids. An estimated 2.4 million children have had a life threatening event where they needed an EpiPen. When the FDA approved Teva’s generic, they intended for Teva to help lower the cost and increase the supply. Tell Teva to cut the price of generic EpiPens. Healthcare in America is changing. Next year the healthcare mandate, that is intended to encourage people to have insurance, will no longer be enforced. So there may be many more uninsured Americans  who need EpiPens. The potential consumption of peanuts and other high-allergy foods shouldn’t cost someone their life. Lives are on the line. Tell Teva to make their generic EpiPens affordable.

Janine Tangney
7,731 supporters
Update posted 7 days ago

Petition to House Energy and Commerce Committee, Subcommittee on Health, Frank Pallone Jr., Joseph P. Kennedy III

Tell the House Subcommittee on Health to make PrEP a part of preventative care

I became a "new case of HIV" in 1991. Most of my friends who contracted HIV (10 to 15 years before me) are dead now. But BECAUSE of them, by 1996, I was on HAART (the cocktail of drugs) that has kept me alive & healthy. Today, there’s a proven way to prevent new cases of HIV, it’s called PrEP, and if it had been available to me & my friends, they wouldn't be dead & I wouldn't have been a "new HIV case." We can end HIV/AIDS in our lifetime. HELP ME! The U.S. Preventive Services Task Force announced that PrEP (aka: Truvada, one of the drugs I take) should be offered by doctors as a major form of HIV prevention. But there’s a huge hurdle to getting on PrEP - the cost. Without insurance, a 30-day supply of PrEP can cost roughly $1,700. Even with insurance, the costs can be prohibitive. But the House Subcommittee on Health can do something about it, they can make PrEP a part of preventative care. This would mean patients could get PrEP for free, no matter the cost. Tell the House to make PrEP a free and essential part of preventative care!The Task Force found that many physicians aren’t offering PrEP for HIV prevention because of the high cost. Once completed, their report will be going to the House Subcommittee on Health and could help expand existing coverage under the Affordable Care Act (ACA), but HIV prevention should go further. An estimated 15% of people with HIV don’t know they have it. In the U.S., HIV rates are actually increasing among Latino and African American men. Southern states had half of all new HIV cases in 2016. With novel preventative drugs like PrEP, countless lives could be saved. Also at risk Women, traditionally ignored in HIV prevention policy, would be benefit if we Demanded that the House make PrEP an essential part of preventative care. In the U.S., 1.2 million people are at high risk of contracting HIV, but only about 80,000 of them had access to PrEP in 2016. That same year, there were 40,000 new cases of HIV in the United States. If high risk people use PrEP everyday, it can reduce their chances of getting HIV from 70-90%. Lives are at stake. Tell the House Subcommittee on Health to make PrEP an essential part of preventative care. No one should lose a friend or relative to complications from HIV/AIDS. Tell the House to make PrEP free. If we ACT TODAY we can end HIV/AIDS. 

Will Scheffer
26,027 supporters
Update posted 1 week ago

Petition to FDA , NIH , MHRA , World Health Organization, European Medicines Agency

Stop the Damage and Find a Cure for Victims of MRI Contrast Toxicity

Thirty million magnetic resonance imaging (MRI) scans are performed each year in the US alone, and many more worldwide. One of every three patients undergoing an MRI scan is injected with the contrast agent, gadolinium. This helps “light up” the results more clearly for the radiologists. Gadolinium is a highly-toxic rare metal. It has no place in the human body. When gadolinium was introduced as a contrast agent, it was prepared in such a way that it was thought to leave the body naturally within 3 days of the MRI scan. Scientific research carried out in the past decade has clearly disproved this. Gadolinium is retained in the body for many years, possibly a lifetime, and concentrates specifically in brain and bones. Tens of millions of patients are exposed to this known toxic substance every year, when they undergo an MRI scan. Many of these patients are young children, whose bodies are still developing. The long-term harm of gadolinium accumulation has not yet been quantified. However, there are already many victims of gadolinium poisoning who suffer painful and crippling symptoms. Recent studies show that gadolinium contrast is used far too liberally and is not necessary in many cases.   We must voice our concerns to the FDA, the World Health Organization and the medical community. We ask the FDA, the World Health Organization and health authorities worldwide to: Warn physicians and patients about the risks of gadolinium. Restrict gadolinium use only to cases where the benefits outweigh the risks. Invest in rapid development of safe gadolinium alternatives. Sponsor large studies of gadolinium toxicity in patients who have undergone MRI scans. Promote the development of effective treatments to remove toxic gadolinium from patients affected by it.

MedInsight Research Institute
7,021 supporters